Cell Proliferation and Viability Assays

A reduction in the number of viable cells after treatment can arise two ways: cells died, or cells stopped dividing. The distinction is not academic. A cytotoxic agent and a cytostatic agent with identical readouts at seventy-two hours require different dosing schedules, behave differently in combination, and carry different expectations for durability of response. An assay reporting a single viability number at a single timepoint cannot tell them apart.

Altogen Labs conducts proliferation and viability assays designed to make that distinction, across validated human cancer cell lines, primary cells, and three-dimensional formats. To discuss an assay design, request a quote.

What different readouts actually measure

Metabolic activity assays report the collective metabolic capacity of a well, which usually tracks cell number but can diverge from it. A compound altering metabolic rate without affecting cell number produces a signal change that is not a viability change, and this is a recognized source of false positives for compounds acting on metabolism.

Membrane integrity assays report cell death directly rather than inferring it from reduced signal. DNA content assays report cell number. Direct cell counting reports the same with fewer assumptions. No single readout answers every question, and selection follows what the study needs to distinguish rather than what is most convenient.

Time course rather than endpoint

Measuring at a single timepoint conflates the two mechanisms. Measuring across a time course separates them. A cytotoxic compound reduces cell number below the seeding density; a cytostatic compound holds it near the starting value while controls proliferate. The shapes are distinguishable, and only from serial measurement.

Washout experiments complete the picture. Removing the compound and continuing culture establishes whether an arrest is reversible, which determines whether intermittent dosing is plausible or whether continuous exposure is required.

Assay conditions that determine the result

Seeding density, exposure duration, serum concentration, and passage number all shift measured potency. A comparison across cell lines is only meaningful if these are held constant, because a line seeded at higher density and assessed at the same timepoint has undergone fewer doublings and will appear less sensitive for reasons unrelated to biology.

Doubling time differs substantially between lines, and an exposure duration representing four doublings for one line may represent one for another. Where a comparison spans lines of different growth rates, exposure duration is set in doublings rather than in hours, or the difference is stated as a limitation.

Applied examples

Cytostatic or cytotoxic. A compound reducing viable cell number by seventy percent at seventy-two hours is assessed across a time course and by washout, establishing reversible arrest rather than cell death, which changes the dosing schedule taken into the animal study.

False positive exclusion. A compound producing a strong signal in a metabolic assay is retested by direct cell counting, establishing that cell number was unchanged and the signal reflected altered metabolism.

Line comparison. A compound is tested across lines of differing doubling time with exposure duration normalized to doublings, producing a potency comparison not confounded by growth rate.

Relationship to other assays

Proliferation and viability data underpin IC50 determination, precede combination testing, and inform which lines are carried into xenograft studies. Where the mechanism of death matters, caspase-based apoptosis assessment establishes whether death proceeds through apoptosis.

Controls and data reporting

Vehicle controls at matched solvent concentration, positive controls, and a baseline measurement at the time of treatment are included, since without the baseline it is impossible to distinguish arrest from death no matter how many later timepoints were taken. Replicate structure and acceptance criteria are defined before the assay runs. Raw values are reported alongside normalized results so a client can re-derive any figure independently.

Send compound, cell lines of interest, and what the assay must distinguish, or request a quote.